A375R cells were generated by continuous selective culture in vemurafenib; immunoblot-detection confirmed PDGFRβ-upregulation in these cells, an established signature molecular change characteristic of vemurafenib-resistant melanoma cells (Figure 6B) [19]. This evidence concerns the gene PDGFRB and melanoma.